Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the role of Breg cells in digestive tract cancer and infectious immunity. | Front Immunol | 2022 | 36618354 | PubTator, text mining | PubMed |
| Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates. | Int J Mol Sci | 2022 | 36613491 | PubTator, text mining | PubMed |
| Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario. | Cancers (Basel) | 2022 | 36612243 | PubTator, text mining | PubMed |
| Merkel Cell Carcinoma-Update on Diagnosis, Management and Future Perspectives. | Cancers (Basel) | 2022 | 36612102 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma. | Front Oncol | 2022 | 36591519 | PubTator, text mining | PubMed |
| In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways. | Front Immunol | 2022 | 36591244 | PubTator, text mining | PubMed |
| Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field. | Front Immunol | 2022 | 36591229 | PubTator, text mining | PubMed |
| Grape seed proanthocyanidin extract induces apoptotic and autophagic cell death in rheumatoid arthritis fibroblast-like synoviocytes. | Arch Rheumatol | 2022 | 36589610 | PubTator, text mining | PubMed |
| Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma. | Front Pharmacol | 2022 | 36588677 | PubTator, text mining | PubMed |
| High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma. | BMC Cancer | 2022 | 36575439 | PubTator, text mining | PubMed |
| Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy. | Front Immunol | 2022 | 36569893 | PubTator, text mining | PubMed |
| Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC. | Commun Biol | 2022 | 36566320 | PubTator, text mining | PubMed |
| Harnessing NK Cells to Control Metastasis. | Vaccines (Basel) | 2022 | 36560427 | PubTator, text mining | PubMed |
| Tissue-Protective and Anti-Inflammatory Landmark of PRP-Treated Mesenchymal Stromal Cells Secretome for Osteoarthritis. | Int J Mol Sci | 2022 | 36555578 | PubTator, text mining | PubMed |
| Rare CNVs and Known Genes Linked to Macrocephaly: Review of Genomic Loci and Promising Candidate Genes. | Genes (Basel) | 2022 | 36553552 | PubTator, text mining | PubMed |
| Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer. | Genes (Basel) | 2022 | 36553542 | PubTator, text mining | PubMed |
| Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer. | Cancers (Basel) | 2022 | 36551617 | PubTator, text mining | PubMed |
| Tumor Microenvironment in Thymic Epithelial Tumors: A Narrative Review. | Cancers (Basel) | 2022 | 36551568 | PubTator, text mining | PubMed |
| A comprehensive bioinformatics analysis of FOXP3 in nonsmall cell lung cancer. | Medicine (Baltimore) | 2022 | 36550816 | PubTator, text mining | PubMed |
| Delivery of Melittin as a Lytic Agent via Graphene Nanoparticles as Carriers to Breast Cancer Cells. | J Funct Biomater | 2022 | 36547538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=40